You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國醫藥(600056.SH):子公司原料藥獲得CEP證書

格隆匯8月13日丨中國醫藥(600056.SH)公佈,公司下屬全資子公司天方藥業有限公司(稱“天方藥業”)收到歐洲藥品質量管理局(EDQM)(簡稱“EDQM”)覈準簽發的克林黴素磷酸酯(簡稱“該藥品”)《歐洲藥典適用性》證書(簡稱“CEP證書”)。該藥品是一種林可黴素類抗生素,主要用於革蘭氏陽性菌和厭氧菌感染。

該藥品CEP證書的獲得,標誌着公司克林黴素磷酸酯產品具備以化學原料藥形式進入歐洲及承認CEP證書的其他規範市場的資質,將有助於拓展國際化業務及增強公司產品在全球市場的競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account